Motor Plasticity, Intermittent Hypoxia and Sleep Apnea
Intermittent Hypoxia (IH), Respiratory and Motor Plasticity, and Sleep Apnea in Spinal Cord Injury (SCI)
1 other identifier
interventional
30
1 country
1
Brief Summary
The purpose of this study is to learn about the effect of sleep apnea and low oxygen on muscle strength and lung function in people with chronic spinal cord injury.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 9, 2019
CompletedFirst Posted
Study publicly available on registry
July 12, 2019
CompletedStudy Start
First participant enrolled
July 16, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2025
CompletedSeptember 8, 2025
September 1, 2025
4 years
July 9, 2019
September 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
The difference in Motor Function assessed via hand grip strength measured by maximum grip strength (MGS) between participants with moderate to severe OSA and without OSA.
Participants will be instructed to squeeze the hand grip dynamometer with maximal effort for 3-5 seconds. This will be repeated three times for each hand with 1 minute of rest between trials. The highest value obtained will be used as the MGS.
Baseline
The difference in Motor Function assessed via hand grip strength measured by electromyographic (EMG) recordings between participants with moderate to severe OSA and without OSA.
Electrodes will be secured on the participant to measure EMG. Participants will then be asked to press the index finger against a custom lever. The participant will perform three brief maximal voluntary contractions (MVC) for 3-5 seconds separated by 60 seconds of rest. The highest of the three values will be used.
Baseline
Secondary Outcomes (3)
Change in Motor Function assessed via hand grip strength measured by MGS.
Baseline to Day 1 post AIH, Baseline to Day 3 post AIH, Baseline to Day 10, Baseline to Day 17
Change in Motor Function assessed via hand grip strength measured by EMG recordings.
Baseline to Day 1 post AIH, Baseline to Day 3 post AIH, Baseline to Day 10, Baseline to Day 17
Change in biomarker levels
Baseline to Day 1 post AIH, Baseline to Day 3 post AIH, Baseline to Day 10, Baseline to Day 17
Study Arms (2)
Moderate to Severe Obstructive Sleep Apnea (OSA)
EXPERIMENTALIndividuals with moderate to severe OSA defined as having an Apnea-hypopnea Index (AHI) that is greater than or equal to 15.
Without OSA
ACTIVE COMPARATORIndividuals without OSA defined as having AHI less than 5.
Interventions
AIH will be administered on days 1-3. Each day entails 15 and 90 second hypoxic intervals (Fraction of Inspired Oxygen (FIO2) = 0.09) alternating with 60-second normoxic intervals (FIO2 = 0.21).
Induced Intermitted hypoxia will be delivered via the AIH mask. The mask has two one-way valves restricting inspiration to the top valve and expiration to the bottom valve. Hypoxic and normoxic gas mixtures will be delivered through the top valve.
Eligibility Criteria
You may qualify if:
- Age 18 or older,
- Chronic (≥ 1-year post-injury), non-progressive SCI,
- Asia Impairment Scale (AIS) C or D,
- Resting Saturated oxygen (SaO2) ≥ 95%,
- Cervical injury (C5-C8)
You may not qualify if:
- Currently hospitalized,
- Resting heart rate ≥120 Beats per minute (BPM),
- Resting systolic blood pressure \>180 mmHg,
- Resting diastolic Blood Pressure \>100 mmHg,
- Self-reported history of unstable angina or myocardial infarction within the previous month,
- OSA that is being treated with positive airway pressure therapy,
- Women who know or suspect they may be pregnant or who may become pregnant,
- Known underlying lung disease,
- Pregnant Women,
- Prisoners,
- Unable to consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Miamilead
- The Craig H. Neilsen Foundationcollaborator
Study Sites (1)
University of Miami
Miami, Florida, 33136, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Shirin Shafazand, MD
University of Miami
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
July 9, 2019
First Posted
July 12, 2019
Study Start
July 16, 2021
Primary Completion
July 1, 2025
Study Completion
July 1, 2025
Last Updated
September 8, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share